Free Trial
OTCMKTS:PKTX

ProtoKinetix (PKTX) Stock Price, News & Analysis

ProtoKinetix logo
$0.01 +0.00 (+26.21%)
As of 04/11/2025 02:10 PM Eastern

About ProtoKinetix Stock (OTCMKTS:PKTX)

Key Stats

Today's Range
$0.0096
$0.0130
50-Day Range
$0.0082
$0.0149
52-Week Range
$0.0080
$0.0190
Volume
75,700 shs
Average Volume
132,783 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing. It has a collaboration research agreement with the University of British Columbia. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incorporated was incorporated in 1999 and is based in Dalton, Ohio.

Remove Ads
Receive PKTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ProtoKinetix and its competitors with MarketBeat's FREE daily newsletter.

PKTX Stock News Headlines

Protokinetix Inc
FNAM Evolutionary Genomics, Inc.
DOGE Social Security bombshell?
Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social Security, finding what he says is widespread fraud across the agency.
Nauticus Robotics And 2 Other Stocks Under $3 Insiders Are Buying
ProtoKinetix, Incorporated (PKTX)
ProtoKinetix Inc PKTX
See More Headlines

PKTX Stock Analysis - Frequently Asked Questions

ProtoKinetix's stock was trading at $0.01 at the beginning of 2025. Since then, PKTX stock has increased by 30.0% and is now trading at $0.0130.
View the best growth stocks for 2025 here
.

Shares of PKTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ProtoKinetix investors own include Sangamo Therapeutics (SGMO), Abrdn Asia-Pacific Income Fund (FAX), MSP Recovery (LIFW), MSP Recovery (LIFW), Fulcrum Therapeutics (FULC), NVIDIA (NVDA) and Tenax Therapeutics (TENX).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:PKTX
Previous Symbol
NASDAQ:PKTX
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (OTCMKTS:PKTX) was last updated on 4/12/2025 by MarketBeat.com Staff
From Our Partners